Intended Use Study of the BD SurePath Plus™ Pap

Clinical trial NCT01234480 · TERMINATED

Trial details

NCT number: NCT01234480
Sponsor: Becton, Dickinson and Company
Status: TERMINATED
Study type: INTERVENTIONAL

Uterine Cervical Neoplasms Uterine Cervical Cancer Neoplasms, Squamous Cell Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Papilloma

Start date: 2010-09-01
Primary completion: 2012-03-01
Enrollment: 5859

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.